Shanghai Fuheng Biotechnology Co., Ltd. 15. Jan. 2025 Injectable supramolecular hydrogel co-loading abemaciclib/NLG919 for neoadjuvant immunotherapy of triple-negative breast cancer - Nature
Shanghai Fuheng Biotechnology Co., Ltd. 16. Juli 2024 Experimental and Therapeutic Medicine - Spandidos Publications